Clinical Trial Update: Study to Evaluate the Effects of Kuvan on Individuals With Phenylketonuria (PKU) With Maladaptive Behaviors

View source ↗

Summary

This Clinical Trial Update reports that a study evaluating Kuvan for individuals with phenylketonuria and maladaptive behaviors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• KUVAN (Sapropterin dihydrochloride)

Snippet

Sponsor: Shoji Yano | Conditions: Phenylketonuria | Status: COMPLETED